<--- Back to Details
First PageDocument Content
Diabetes / Boehringer Ingelheim / Pyridines / Eli Lilly and Company / Dabigatran / Metabolic syndrome / National Institutes of Health / Diabetic nephropathy / Ingelheim am Rhein / Chemistry / Medicine / Health
Date: 2015-06-02 16:58:55
Diabetes
Boehringer Ingelheim
Pyridines
Eli Lilly and Company
Dabigatran
Metabolic syndrome
National Institutes of Health
Diabetic nephropathy
Ingelheim am Rhein
Chemistry
Medicine
Health

shutterstock_116875702_yellow.eps

Add to Reading List

Source URL: partnering.boehringer-ingelheim.com

Download Document from Source Website

File Size: 2,03 MB

Share Document on Facebook

Similar Documents

Innovation / States of Germany / Boehringer Ingelheim / Business / Open innovation / Patent / Science and technology / Boehringer / Ingelheim am Rhein

Open Innovation & IP: Views from the Pharmaceutical Innovative Industry Gauthier Obrecht

DocID: 1qEm3 - View Document

Urban planning / Assistive technology / Augmentative and alternative communication / Coloradd / Vision / Accessibility / Buddhism / Color blindness / Ashoka / YouTube / Ingelheim am Rhein

ColorADD, Color Identification System INNOVATION AND SOCIAL RESPONSIBLE ColorADD, COLOR IS FOR ALL! ColorADD is a unique, universal, inclusive and non-discriminative language that enables the colorblind to identify color

DocID: 1qC8X - View Document

Boehringer Ingelheim / States of Germany / Boehringer / Economy of Germany / Ingelheim am Rhein / Rhineland-Palatinate

Press release Update on Polyphor Ltd and Boehringer Ingelheim collaboration Release (July 31, 2013, 7 am CEST) Polyphor achieves first milestone in macrocycle drug discovery collaboration with Boehringer Ingelheim

DocID: 1qab2 - View Document

Boehringer Ingelheim / Boehringer / Ingelheim am Rhein / Pharmaceutical industry in China

Boehringer Ingelheim Biopharma forms strategic partnership with Zai Lab   

DocID: 1ppUW - View Document

Anfahrt Ingelheim Boehringer Ingelheim Binger StraßeIngelheim am Rhein Tel.: Fax:

DocID: 1gNoK - View Document